ATRA vs AAPL: Which Stock is Better?
Side-by-side comparison of Atara Biotherapeutics Inc and Apple Inc in 2026
ATRA
Atara Biotherapeutics Inc
$4.32
AAPL
Apple Inc
$246.86
Key Metrics Comparison
| Metric | ATRA | AAPL | Winner |
|---|---|---|---|
| Market Cap | $32.73M | $3.66T | AAPL |
| P/E Ratio | 1.59 | 33.85 | ATRA |
| EPS (TTM) | $2.86 | $7.55 | AAPL |
| Revenue Growth | -0.9% | 6.4% | AAPL |
| Gross Margin | 46.8% | 46.9% | AAPL |
Analyze ATRA
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ATRA or AAPL a better investment?
Comparing ATRA and AAPL: Atara Biotherapeutics Inc has a market cap of $32.73M while Apple Inc has $3.66T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ATRA and AAPL?
ATRA (Atara Biotherapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ATRA or AAPL?
Based on P/E ratios, ATRA trades at a lower multiple (1.6x vs 33.8x).
Which is growing faster: ATRA or AAPL?
AAPL has higher revenue growth at 6.4% vs -0.9% for ATRA.
Which company is more profitable: ATRA or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 46.8% for ATRA.
Which is the larger company: ATRA or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.66T compared to $32.73M for ATRA.
Should I buy ATRA or AAPL in 2026?
Both ATRA and AAPL have investment merit. ATRA trades at $4.32 while AAPL trades at $246.86. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ATRA and AAPL stock?
Key differences: Market Cap ($32.73M vs $3.66T), P/E Ratio (1.6x vs 33.8x), Revenue Growth (-0.9% vs 6.4%), Gross Margin (46.8% vs 46.9%).